O-tetradecanoyl-L-carnitine

Metabolite details

Identifier

PSHXNVGSVNEJBD-LJQANCHMSA-N

InChI Key

PSHXNVGSVNEJBD-LJQANCHMSA-N

IUPAC name

(3R)-3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate

Preferred name

O-tetradecanoyl-L-carnitine

INN name

—

Synonym

(R)-myristoylcarnitine

ChEBI

CHEBI:84634

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Biological effect of chronic mistranslation in mammalian cells
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Metabolic characterization of the natural progression of chronic hepatitis B (Biogenic amine and Acyl-carnitine assays).
• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids

Observed in differential profiles

• rps2_wildtype_vs_rps2_A226Y
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_vs_Immune_Tolerant
• Control_vs_OXPA_Treatment
• G1_Control_vs_G2_Arginine_Addition